Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 114

Sort by

Sort Order Select

Journal Articles

Isatuximab (Isa) subcutaneous (SC) via an on-body injector (OBI) vs isa intravenous (IV), plus pomalidomide and dexamethasone (Pd) in relapsed/refractory multiple myeloma (RRMM): East asia subgroup results from the randomized, non-inferiority, phase 3 iraklia study

Blood (2025) 146 (Supplement 1): 5819.

https://doi.org/10.1182/blood-2025-5819

Published: 2025

Journal Articles

Tracking MRD in multiple myeloma: Soluble BCMA reflects flow cytometry changes

Masanori Toho, Rikako Tabata, Atsushi Uehara, Naoya Fukuda, Kosuke Shima, Daichi Terunuma, Fuminari Fujii, Hajime Sakuma, Kentaro Narita, Masami Takeuchi, Kosei Matsue

Blood (2025) 146 (Supplement 1): 2232.

https://doi.org/10.1182/blood-2025-2232

Published: 2025

Journal Articles

Distinct blood endothelial cells shape spatial niches in angioimmunoblastic T-cell lymphoma

Blood (2025) 146 (Supplement 1): 462.

https://doi.org/10.1182/blood-2025-462

Published: 2025

Journal Articles

Outcomes of relapsed or refractory mature T/NK-cell lymphomas in the era of novel agents: A nationwide observational Study in Japan

Blood (2025) 146 (Supplement 1): 1865.

https://doi.org/10.1182/blood-2025-1865

Published: 2025

Journal Articles

Radiomic features from PET-CT enable diagnostic and prognostic stratification in peripheral T-cell lymphoma

Hajime Sakuma, Daisuke Ikeda, Youichi Machida, Fukuda Naoya, Fuminari Fujii, Daichi Terunuma, Kosuke Shima, Masanori Toho, Atsushi Uehara, Kentaro Narita, Masami Takeuchi, Kosei Matsue

Blood (2025) 146 (Supplement 1): 5333.

https://doi.org/10.1182/blood-2025-5333

Published: 2025

Journal Articles

Soluble B-cell maturation antigen levels for disease monitoring in oligosecretory and nonsecretory relapsed multiple myeloma

Daisuke Ikeda, Shuichi Aikawa, Chiho Misono, Mitsuaki Oura, Fuminari Fujii, Hajime Sakuma, Masanori Toho, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Tomohisa Watari, Yoshihito Otsuka, Kosei Matsue

Blood (2025) 145 (5): 526–532.

https://doi.org/10.1182/blood.2024026028

Published: 2025

Includes: Supplemental data

Journal Articles

Impact of Mutational Landscape and Biomarkers on Response of Luspatercept (ACE-536) Treatment of Anemia in Non-Transfusion Dependent IPSS-R Lower Risk MDS Japanese Subjects (ACE-536-MDS-003- a Ph2 single-arm study)

Bijay Shankar Jaiswal, Manuel Ugidos, Hiroshi Kosugi, Kosei Matsue, Hiromi Murakami, Jin Hayakawa, Daniel Lopes de Menezes, Anita K. Gandhi, Rajasekhar N.V.S. Suragani

Blood (2024) 144 (Supplement 1): 6725.

https://doi.org/10.1182/blood-2024-201883

Published: 2024

Journal Articles

Impact of Cooperating Myeloid Gene Mutations on Disease Progression and Survival in Japanese MPN Patients: A Multicenter Study

Blood (2024) 144 (Supplement 1): 1805.

https://doi.org/10.1182/blood-2024-208908

Published: 2024

Journal Articles

Spatially Resolved Single-Cell Transcriptomics of T Cells in Follicular Lymphoma Reveals Distinct Immune Ecosystems

Blood (2024) 144 (Supplement 1): 741.

https://doi.org/10.1182/blood-2024-201171

Published: 2024

Journal Articles

Simultaneous Assessment of Total Metabolic Tumor Volume and Intratumoral CD4+ T-Cell Infiltration Identifies Early Progression of Follicular Lymphoma on Watch-and-Wait Approach

Fuminari Fujii, Daisuke Ikeda, Hajime Sakuma, Mitsuaki Oura, Masanori Toho, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Kosei Matsue

Blood (2024) 144 (Supplement 1): 3042.

https://doi.org/10.1182/blood-2024-210742

Published: 2024

Journal Articles

Serum BCMA Is a Better Reflector of Tumor Volume Than IgM in the Induction Period of Waldenström Macroglobulinemia

Mitsuaki Oura, Daisuke Ikeda, Chiho Misono, Shuichi Aikawa, Fuminari Fujii, Hajime Sakuma, Masanori Toho, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Tomohisa Watari, Yoshihito Otsuka, Masami Takeuchi, Kosei Matsue

Blood (2024) 144 (Supplement 1): 3035.

https://doi.org/10.1182/blood-2024-202282

Published: 2024

Journal Articles

Total Diffusion Volume Evaluated By Whole-Body Diffusion Weighted Magnetic Resonance Image for the Assessment of Tumor Burden in Multiple Myeloma; Relations with Measurable Residual Disease Evaluated By Next-Generation Flow Cytometry and Bone Marrow CD138 Staining Assessed By Qupath

Kentaro Narita, Youichi Machida, Daisuke Ikeda, Rikako Tabata, Atsushi Uehara, Mitsuaki Oura, Fuminari Fujii, Hajime Sakuma, Masami Takeuchi, Kosei Matsue

Blood (2024) 144 (Supplement 1): 491.

https://doi.org/10.1182/blood-2024-199873

Published: 2024

Journal Articles

Efficacy and Safety of Talquetamab, a GPRC5D×CD3 Bispecific Antibody, in Japanese Patients with Relapsed/Refractory Multiple Myeloma from the Phase 1/2 Monumental-1 Study

Shigeki Ito, Yoshiaki Kuroda, Kazutaka Sunami, Kosei Matsue, Kazunori Imada, Hideto Tamura, Mikihiro Takamoto, Hiroshi Yamazaki, Ei Fujikawa, Lixia Pei, Tara J Masterson, Michela Campagna, Bonnie W Lau, Yasushi Takamatsu

Blood (2024) 144 (Supplement 1): 7011.

https://doi.org/10.1182/blood-2024-199663

Published: 2024

Journal Articles

Different Patterns of Antigen Expression in Bone Marrow and Circulating Tumor Plasma Cells in Patients with MGUS and Smoldering Multiple Myeloma

Atsushi Uehara, Fuminari Fujii, Hajime Sakuma, Mitsuaki Oura, Masanori Toho, Daisuke Ikeda, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Kosei Matsue

Blood (2024) 144 (Supplement 1): 4682.

https://doi.org/10.1182/blood-2024-206782

Published: 2024

Journal Articles

Prognostic Value of t(11;14)(q13;32) in Newly Diagnosed Myeloma Patients in Novel Agent Era; Matched-Pair Analysis

Yuka Shimada, Daisuke Miura, Ami Inokuchi, Daisuke Ikeda, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Kosei Matsue

Blood (2024) 144 (Supplement 1): 1931.

https://doi.org/10.1182/blood-2024-194325

Published: 2024

Journal Articles

Soluble B-Cell Maturation Antigen Levels for Disease Monitoring in Oligo- and Non-Secretory Relapsed Multiple Myeloma

Blood (2024) 144 (Supplement 1): 366.

https://doi.org/10.1182/blood-2024-207595

Published: 2024

Journal Articles

Soluble BCMA As a Surrogate Biomarker for Tumor Burden in Multiple Myeloma: Correlations with Various Biomarkers and Treatment Responses

Rikako Tabata, Mitsuaki Oura, Daisuke Ikeda, Shuichi Aikawa, Chiho Misono, Fuminari Fujii, Hajime Sakuma, Masanori Toho, Atsushi Uehara, Kentaro Narita, Masami Takeuchi, Tomohisa Watari, Yoshihito Otsuka, Kosei Matsue

Blood (2024) 144 (Supplement 1): 3313.

https://doi.org/10.1182/blood-2024-211840

Published: 2024

Journal Articles

ALK-positive anaplastic large cell lymphoma, Hodgkin-like pattern with unexplained fever

Rikako Tabata, Kosei Matsue

Blood (2024) 144 (13): 1460.

https://doi.org/10.1182/blood.2024024998

Published: 2024

Journal Articles

A Prognostic Model Integrating Circulating Clonal Plasma Cells into R-ISS and PET-CT Based Tumor Burden in Transplant-Ineligible Multiple Myeloma

Daisuke Ikeda, Toshiki Terao, Mitsuaki Oura, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Youichi Machida, Kosei Matsue

Blood (2023) 142 (Supplement 1): 1972.

https://doi.org/10.1182/blood-2023-189137

Published: 2023

Journal Articles

Distinct Minor Neoplastic Follicular T-Cell Subsets Dictate Lymphoma Fates through Functional Specialization

Blood (2023) 142 (Supplement 1): 430.

https://doi.org/10.1182/blood-2023-180518

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Isatuximab (Isa) subcutaneous (SC) via an on-body injector (OBI) vs isa intravenous (IV), plus pomalidomide and dexamethasone (Pd) in relapsed/refractory multiple myeloma (RRMM): East asia subgroup results from the randomized, non-inferiority, phase 3 iraklia study

Tracking MRD in multiple myeloma: Soluble BCMA reflects flow cytometry changes

Distinct blood endothelial cells shape spatial niches in angioimmunoblastic T-cell lymphoma

Outcomes of relapsed or refractory mature T/NK-cell lymphomas in the era of novel agents: A nationwide observational Study in Japan

Radiomic features from PET-CT enable diagnostic and prognostic stratification in peripheral T-cell lymphoma

Soluble B-cell maturation antigen levels for disease monitoring in oligosecretory and nonsecretory relapsed multiple myeloma

Impact of Mutational Landscape and Biomarkers on Response of Luspatercept (ACE-536) Treatment of Anemia in Non-Transfusion Dependent IPSS-R Lower Risk MDS Japanese Subjects (ACE-536-MDS-003- a Ph2 single-arm study)

Impact of Cooperating Myeloid Gene Mutations on Disease Progression and Survival in Japanese MPN Patients: A Multicenter Study

Spatially Resolved Single-Cell Transcriptomics of T Cells in Follicular Lymphoma Reveals Distinct Immune Ecosystems

Simultaneous Assessment of Total Metabolic Tumor Volume and Intratumoral CD4+ T-Cell Infiltration Identifies Early Progression of Follicular Lymphoma on Watch-and-Wait Approach

Serum BCMA Is a Better Reflector of Tumor Volume Than IgM in the Induction Period of Waldenström Macroglobulinemia

Total Diffusion Volume Evaluated By Whole-Body Diffusion Weighted Magnetic Resonance Image for the Assessment of Tumor Burden in Multiple Myeloma; Relations with Measurable Residual Disease Evaluated By Next-Generation Flow Cytometry and Bone Marrow CD138 Staining Assessed By Qupath

Efficacy and Safety of Talquetamab, a GPRC5D×CD3 Bispecific Antibody, in Japanese Patients with Relapsed/Refractory Multiple Myeloma from the Phase 1/2 Monumental-1 Study

Different Patterns of Antigen Expression in Bone Marrow and Circulating Tumor Plasma Cells in Patients with MGUS and Smoldering Multiple Myeloma

Prognostic Value of t(11;14)(q13;32) in Newly Diagnosed Myeloma Patients in Novel Agent Era; Matched-Pair Analysis

Soluble B-Cell Maturation Antigen Levels for Disease Monitoring in Oligo- and Non-Secretory Relapsed Multiple Myeloma

Soluble BCMA As a Surrogate Biomarker for Tumor Burden in Multiple Myeloma: Correlations with Various Biomarkers and Treatment Responses

ALK-positive anaplastic large cell lymphoma, Hodgkin-like pattern with unexplained fever

A Prognostic Model Integrating Circulating Clonal Plasma Cells into R-ISS and PET-CT Based Tumor Burden in Transplant-Ineligible Multiple Myeloma

Distinct Minor Neoplastic Follicular T-Cell Subsets Dictate Lymphoma Fates through Functional Specialization

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only